We’re evaluating a new procedure to help lower HbA1c and better manage daily blood sugar. This is a same-day, non-surgical treatment for adults with Type 2 Diabetes.
If you're living with Type 2 Diabetes and looking for new ways to reach your health goals, the RESTORE-1 Clinical Research Study might be right for you.
The RESTORE-1 study is evaluating an investigational procedure that targets the small intestine to help the body naturally regulate blood sugar.
A specialized physician performs the procedure entirely through a flexible tube passed through the mouth to treat the small bowel. There are no surgical cuts and no permanent implants left behind.
The procedure uses standard, routine medical sedation so that you remain completely comfortable and asleep throughout.
Review the simple checklists below. If your current health matches these points, you may be an ideal candidate for this study.
Are an adult between 18 - 65 living with Type 2 Diabetes.
Have BMI 25 - 40 kg.
Take at least one type of diabetes medications.
Are an adult between 18 - 65 living with Type 2 Diabetes.
Have had prior bariatric (gastric bypass or weight-loss) surgery.
Have severe, chronic stomach or intestinal diseases.
If you qualify and choose to Join:
All study-related medical evaluations, blood work, procedures, and follow-up care are provided at no cost to you. + compensation for their participation.
You will be closely monitored by a team of specialized diabetes doctors and research staff.
Your participation is 100% voluntary. You can change your mind and withdraw from the study at any time, for any reason.
Your personal and medical information is completely safe. The screening quiz is fully encrypted, secure, and will never be shared without your explicit permission.
If you are ready to see if the RESTORE-1 study is for you, choose an option below to connect with our secure, IRB-approved screening portal.
To learn more about current research opportunities or see if you qualify, visit the ClinicalTrials.gov webpage
View the map below to see which clinical study site is nearest to you.
Aqua Medical is a U.S.-based clinical-stage medical technology company advancing a minimally invasive, through-the-working-channel-of-the-scope technology to address type 2 diabetes. Using its proprietary radiofrequency vapor ablation (RFVA) system for the Proximal Intestinal Mucosal Ablation (PIMA) procedure, the company aims to deliver scalable, device-based therapies that address the underlying disease pathology, eliminate medication dependence, and improve long-term patient outcomes.
The RFVA system is FDA-cleared for marketing for its indicated use in the gastrointestinal tract. Use of the RFVA system for the PIMA procedure is investigational. The safety and effectiveness of the RFVA system for the PIMA procedure have not yet been established.
